HUMAN
IMMUNODEFICIENCY VIRUS INFECTION / ACQUIRED IMMUNODEFICIENCY SYNDROME (HIV/AIDS)
is a disease of the human immune system caused by infection with human immunodeficiency
virus (HIV). During the initial infection, a person may experience a brief
period of influenza-like illness. This is typically followed by a prolonged
period without symptoms. As the illness progresses, it interferes more and more
with the immune system, making the person much more likely to get infections,
including opportunistic infections and tumors that do not usually affect people
who have working immune systems.
HIV
is transmitted primarily via unprotected sexual intercourse (including anal and
even oral sex), contaminated blood transfusions, hypodermic needles, and from
mother to child during pregnancy, delivery, or breastfeeding. Some bodily
fluids, such as saliva and tears, do not transmit HIV. Prevention of HIV
infection, primarily through safe sex and needle-exchange programs, is a key
strategy to control the spread of the disease. There is no cure or vaccine;
however, antiretroviral treatment can slow the course of the disease and may
lead to a near-normal life expectancy. While antiretroviral treatment reduces
the risk of death and complications from the disease, these medications are
expensive and may be associated with side effects.
Acquired immunodeficiency syndrome
Main symptoms of AIDS.
Acquired immunodeficiency
syndrome (AIDS) is defined in terms of either a CD4+ T cell count
below 200 cells per µL or the occurrence of specific diseases in association
with an HIV infection. In the absence of
specific treatment, around half of people infected with HIV develop AIDS within
ten years. The most common initial
conditions that alert to the presence of AIDS are pneumocystis
pneumonia (40%), cachexia in the form
of HIV wasting syndrome (20%) and esophageal
candidiasis. Other common signs
include recurring respiratory
tract infections
Genetic
research indicates that HIV originated in west-central Africa during the early
twentieth century.
Transmission
Average per act risk of getting HIV
by exposure route to an infected source |
||
Exposure route
|
Chance of infection
|
|
Blood transfusion
|
90%
|
|
Childbirth (to child)
|
25%
|
|
Needle-sharing injection drug use
|
0.67%
|
|
Percutaneous needle stick
|
0.30%
|
|
Receptive anal intercourse*
|
0.04–3.0%
|
|
Insertive anal intercourse*
|
0.03%
|
|
Receptive penile-vaginal intercourse*
|
0.05–0.30%
|
|
Insertive penile-vaginal intercourse*
|
0.01–0.38%
|
|
Receptive oral intercourse*§
|
0–0.04%
|
|
Insertive oral intercourse*§
|
0–0.005%
|
|
* assuming no condom use
§ source refers to oral intercourse performed on a man |
HIV is transmitted by three main
routes: sexual contact,
exposure to infected body fluids or tissues, and from mother to child during
pregnancy, delivery, or breastfeeding (known as vertical
transmission). There
is no risk of acquiring HIV if exposed to feces,
nasal secretions, saliva, sputum, sweat, tears,
urine, or vomit unless these are contaminated with blood. It is possible to be co-infected by more than one strain of HIV a
condition known as HIV superinfection.[33]
Sexual
The most frequent mode of
transmission of HIV is through sexual contact with an infected person.
The majority of all transmissions
worldwide occur through heterosexual
contacts (i.e. sexual contacts between people of the opposite sex);[ however, the pattern of
transmission varies significantly among countries. In the United States, as of
2009, most sexual transmission occurred in men who had sex
with men, with this population accounting for 64% of all new cases.
As regards unprotected heterosexual contacts,
estimates of the risk of HIV transmission per sexual act appear to be four to
ten times higher in low-income countries than in high-income countries. In low-income countries, the risk of
female-to-male transmission is estimated as 0.38% per act, and of
male-to-female transmission as 0.30% per act; the equivalent estimates for
high-income countries are 0.04% per act for female-to-male transmission, and
0.08% per act for male-to-female transmission. The risk of transmission from anal intercourse
is especially high, estimated as 1.4–1.7% per act in both heterosexual and homosexual
contacts. While the risk of transmission from oral sex is relatively low, it is still
present. The risk from receiving oral sex has been
described as "nearly nil" however a few
cases have been reported. The per-act risk is estimated at 0–0.04% for
receptive oral intercourse. In settings involving prostitution in low income countries, risk
of female-to-male transmission has been estimated as 2.4% per act and
male-to-female transmission as 0.05% per act.
Risk of transmission increases
in the presence of many sexually
transmitted infections[41] and genital ulcers.[35] Genital ulcers appear to
increase the risk approximately fivefold.[35] Other sexually transmitted
infections, such as gonorrhea, chlamydia,
trichomoniasis, and bacterial vaginosis,
are associated with somewhat smaller increases in risk of transmission.[40]
The viral load of an infected person is an
important risk factor in both sexual and mother-to-child transmission. During
the first 2.5 months of an HIV infection a person's infectiousness is
twelve times higher due to this high viral load. If the person is in the late
stages of infection, rates of transmission are approximately eightfold greater.
Commercial sex workers
(including those
in pornography) have an increased rate of HIV.[43][44] Rough sex can be a factor associated with
an increased risk of transmission.[45] Sexual assault is also believed to carry an
increased risk of HIV transmission as condoms are rarely worn, physical trauma
to the vagina or rectum is likely, and there may be a greater risk of
concurrent sexually transmitted infections.
Body fluids
The second most frequent mode of
HIV transmission is via blood and blood products. Blood-borne transmission can be
through needle-sharing during intravenous drug use, needle stick injury,
transfusion of contaminated blood or blood product, or medical injections with
unsterilised equipment. The risk from sharing a needle during drug injection is between 0.63 and 2.4% per
act, with an average of 0.8%. The risk of acquiring HIV from a needle stick
from an HIV-infected person is estimated as 0.3% (about 1 in 333) per act and
the risk following mucus membrane
exposure to infected blood as 0.09% (about 1 in 1000) per act. In the United
States intravenous drug users made up 12% of all new cases of HIV in 2009, and
in some areas more than 80% of people who inject drugs are HIV positive.
HIV is transmitted in About 93%
of blood transfusions
involving infected blood. In developed countries the risk of acquiring HIV from
a blood transfusion is extremely low (less than one in half a million) where
improved donor selection and HIV screening is performed; for example, in the UK the risk is
reported at one in five million. In low income
countries, only half of transfusions may be appropriately screened (as of 2008), and it is estimated that up to 15% of
HIV infections in these areas come from transfusion of infected blood and blood
products, representing between 5% and 10% of global infections.
Unsafe medical injections play a
significant role in HIV spread in sub-Saharan Africa. In 2007, between 12 and
17% of infections in this region were attributed to medical syringe use. The
World Health Organisation estimates the risk of transmission as a result of a
medical injection in Africa at 1.2%.
Significant risks are also associated with invasive procedures, assisted
delivery, and dental care in this area of the world.
People giving or receiving tattoos, piercings, and scarification are theoretically at risk of
infection but no confirmed cases have been documented. It is not possible for mosquitoes or other insects to transmit HIV.
Mother-to-child
HIV can be transmitted from
mother to child during pregnancy, during delivery, or through breast milk. This
is the third most common way in which HIV is transmitted globally. In the
absence of treatment, the risk of transmission before or during birth is around
20% and in those who also breastfeed 35%. As
of 2008, vertical transmission accounted for about 90% of cases of HIV in
children. With appropriate treatment the risk of mother-to-child infection can
be reduced to about 1%. Preventive
treatment involves the mother taking antiretroviral during pregnancy and
delivery, an elective caesarean section,
avoiding breastfeeding, and administering antiretroviral drugs to the newborn.
Many of these measures are however not available in the developing world. If blood contaminates food during pre-chewing it may pose a risk of
transmission
No comments:
Post a Comment